ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
DBX2
|
ENSG00000185610.6 | DBX2 |
HLX
|
ENSG00000136630.11 | HLX |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HLX | hg19_v2_chr1_+_221051699_221051699 | 0.42 | 1.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_130126165 | 2.78 |
ENST00000427521.1 ENST00000416162.2 ENST00000378576.4 |
MEST |
mesoderm specific transcript |
chr7_+_130126012 | 2.68 |
ENST00000341441.5 |
MEST |
mesoderm specific transcript |
chr1_+_81771806 | 2.12 |
ENST00000370721.1 ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2 |
latrophilin 2 |
chr6_-_52859046 | 1.96 |
ENST00000457564.1 ENST00000541324.1 ENST00000370960.1 |
GSTA4 |
glutathione S-transferase alpha 4 |
chr19_+_50016610 | 1.93 |
ENST00000596975.1 |
FCGRT |
Fc fragment of IgG, receptor, transporter, alpha |
chr17_+_1674982 | 1.78 |
ENST00000572048.1 ENST00000573763.1 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr11_+_5710919 | 1.70 |
ENST00000379965.3 ENST00000425490.1 |
TRIM22 |
tripartite motif containing 22 |
chr8_-_13134045 | 1.62 |
ENST00000512044.2 |
DLC1 |
deleted in liver cancer 1 |
chr11_-_63376013 | 1.61 |
ENST00000540943.1 |
PLA2G16 |
phospholipase A2, group XVI |
chr5_-_125930929 | 1.53 |
ENST00000553117.1 ENST00000447989.2 ENST00000409134.3 |
ALDH7A1 |
aldehyde dehydrogenase 7 family, member A1 |
chr4_-_110723194 | 1.44 |
ENST00000394635.3 |
CFI |
complement factor I |
chr19_+_50016411 | 1.35 |
ENST00000426395.3 ENST00000600273.1 ENST00000599988.1 |
FCGRT |
Fc fragment of IgG, receptor, transporter, alpha |
chr16_+_14802801 | 1.27 |
ENST00000526520.1 ENST00000531598.2 |
NPIPA3 |
nuclear pore complex interacting protein family, member A3 |
chr2_+_11696464 | 1.22 |
ENST00000234142.5 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr6_+_114178512 | 1.19 |
ENST00000368635.4 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
chr3_-_123512688 | 1.18 |
ENST00000475616.1 |
MYLK |
myosin light chain kinase |
chr4_-_110723134 | 1.16 |
ENST00000510800.1 ENST00000512148.1 |
CFI |
complement factor I |
chr10_+_5135981 | 1.13 |
ENST00000380554.3 |
AKR1C3 |
aldo-keto reductase family 1, member C3 |
chr2_+_85811525 | 1.10 |
ENST00000306384.4 |
VAMP5 |
vesicle-associated membrane protein 5 |
chr16_-_28634874 | 1.08 |
ENST00000395609.1 ENST00000350842.4 |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
chr12_+_26348429 | 1.07 |
ENST00000242729.2 |
SSPN |
sarcospan |
chr8_+_97597148 | 1.05 |
ENST00000521590.1 |
SDC2 |
syndecan 2 |
chr17_-_64225508 | 1.05 |
ENST00000205948.6 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr12_+_26348246 | 1.04 |
ENST00000422622.2 |
SSPN |
sarcospan |
chr11_-_104827425 | 1.04 |
ENST00000393150.3 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
chr8_+_98900132 | 0.99 |
ENST00000520016.1 |
MATN2 |
matrilin 2 |
chr7_+_134576317 | 0.98 |
ENST00000424922.1 ENST00000495522.1 |
CALD1 |
caldesmon 1 |
chrX_-_106243451 | 0.98 |
ENST00000355610.4 ENST00000535534.1 |
MORC4 |
MORC family CW-type zinc finger 4 |
chr3_-_194072019 | 0.96 |
ENST00000429275.1 ENST00000323830.3 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
chr3_-_114790179 | 0.96 |
ENST00000462705.1 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr12_-_91505608 | 0.94 |
ENST00000266718.4 |
LUM |
lumican |
chr14_-_53331239 | 0.93 |
ENST00000553663.1 |
FERMT2 |
fermitin family member 2 |
chr12_-_91573132 | 0.92 |
ENST00000550563.1 ENST00000546370.1 |
DCN |
decorin |
chr15_+_25200074 | 0.89 |
ENST00000390687.4 ENST00000584968.1 ENST00000346403.6 ENST00000554227.2 |
SNRPN |
small nuclear ribonucleoprotein polypeptide N |
chr20_-_33735070 | 0.87 |
ENST00000374491.3 ENST00000542871.1 ENST00000374492.3 |
EDEM2 |
ER degradation enhancer, mannosidase alpha-like 2 |
chr16_-_30122717 | 0.85 |
ENST00000566613.1 |
GDPD3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
chr7_-_87342564 | 0.85 |
ENST00000265724.3 ENST00000416177.1 |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
chr12_+_81110684 | 0.84 |
ENST00000228644.3 |
MYF5 |
myogenic factor 5 |
chr14_-_54423529 | 0.83 |
ENST00000245451.4 ENST00000559087.1 |
BMP4 |
bone morphogenetic protein 4 |
chr16_-_28937027 | 0.83 |
ENST00000358201.4 |
RABEP2 |
rabaptin, RAB GTPase binding effector protein 2 |
chr3_-_48130707 | 0.83 |
ENST00000360240.6 ENST00000383737.4 |
MAP4 |
microtubule-associated protein 4 |
chr5_-_146781153 | 0.82 |
ENST00000520473.1 |
DPYSL3 |
dihydropyrimidinase-like 3 |
chr7_+_134576151 | 0.82 |
ENST00000393118.2 |
CALD1 |
caldesmon 1 |
chr15_+_25200108 | 0.81 |
ENST00000577949.1 ENST00000338094.6 ENST00000338327.4 ENST00000579070.1 ENST00000577565.1 |
SNURF SNRPN |
SNRPN upstream reading frame protein small nuclear ribonucleoprotein polypeptide N |
chr11_-_104817919 | 0.81 |
ENST00000533252.1 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
chr1_-_89591749 | 0.79 |
ENST00000370466.3 |
GBP2 |
guanylate binding protein 2, interferon-inducible |
chr10_-_52645379 | 0.73 |
ENST00000395489.2 |
A1CF |
APOBEC1 complementation factor |
chr2_+_11674213 | 0.72 |
ENST00000381486.2 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr11_-_2162468 | 0.68 |
ENST00000434045.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr2_+_102413726 | 0.67 |
ENST00000350878.4 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
chr1_-_110283138 | 0.67 |
ENST00000256594.3 |
GSTM3 |
glutathione S-transferase mu 3 (brain) |
chr13_-_46679185 | 0.67 |
ENST00000439329.3 |
CPB2 |
carboxypeptidase B2 (plasma) |
chr13_-_46679144 | 0.66 |
ENST00000181383.4 |
CPB2 |
carboxypeptidase B2 (plasma) |
chr14_-_25479811 | 0.66 |
ENST00000550887.1 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
chr12_+_75874580 | 0.65 |
ENST00000456650.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr12_+_75874460 | 0.65 |
ENST00000266659.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr4_+_69962185 | 0.64 |
ENST00000305231.7 |
UGT2B7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr4_+_146403912 | 0.64 |
ENST00000507367.1 ENST00000394092.2 ENST00000515385.1 |
SMAD1 |
SMAD family member 1 |
chr12_+_75874984 | 0.63 |
ENST00000550491.1 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr4_+_74301880 | 0.62 |
ENST00000395792.2 ENST00000226359.2 |
AFP |
alpha-fetoprotein |
chr9_+_116207007 | 0.62 |
ENST00000374140.2 |
RGS3 |
regulator of G-protein signaling 3 |
chr4_+_69962212 | 0.61 |
ENST00000508661.1 |
UGT2B7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr6_-_52859968 | 0.61 |
ENST00000370959.1 |
GSTA4 |
glutathione S-transferase alpha 4 |
chrX_-_130423200 | 0.59 |
ENST00000361420.3 |
IGSF1 |
immunoglobulin superfamily, member 1 |
chr1_+_84630645 | 0.58 |
ENST00000394839.2 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chr4_+_69681710 | 0.57 |
ENST00000265403.7 ENST00000458688.2 |
UGT2B10 |
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr6_-_152639479 | 0.56 |
ENST00000356820.4 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
chr11_+_35201826 | 0.56 |
ENST00000531873.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr5_+_82767487 | 0.55 |
ENST00000343200.5 ENST00000342785.4 |
VCAN |
versican |
chr6_+_121756809 | 0.55 |
ENST00000282561.3 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
chr10_-_95241951 | 0.55 |
ENST00000358334.5 ENST00000359263.4 ENST00000371488.3 |
MYOF |
myoferlin |
chr10_-_95242044 | 0.54 |
ENST00000371501.4 ENST00000371502.4 ENST00000371489.1 |
MYOF |
myoferlin |
chr15_+_58724184 | 0.54 |
ENST00000433326.2 |
LIPC |
lipase, hepatic |
chr2_-_225811747 | 0.52 |
ENST00000409592.3 |
DOCK10 |
dedicator of cytokinesis 10 |
chr4_-_186456652 | 0.51 |
ENST00000284767.5 ENST00000284770.5 |
PDLIM3 |
PDZ and LIM domain 3 |
chr4_+_155484155 | 0.50 |
ENST00000509493.1 |
FGB |
fibrinogen beta chain |
chr4_-_186456766 | 0.50 |
ENST00000284771.6 |
PDLIM3 |
PDZ and LIM domain 3 |
chr11_-_13517565 | 0.49 |
ENST00000282091.1 ENST00000529816.1 |
PTH |
parathyroid hormone |
chr2_+_161993412 | 0.49 |
ENST00000259075.2 ENST00000432002.1 |
TANK |
TRAF family member-associated NFKB activator |
chr11_+_101983176 | 0.48 |
ENST00000524575.1 |
YAP1 |
Yes-associated protein 1 |
chr11_-_124670550 | 0.48 |
ENST00000239614.4 |
MSANTD2 |
Myb/SANT-like DNA-binding domain containing 2 |
chr6_-_52705641 | 0.47 |
ENST00000370989.2 |
GSTA5 |
glutathione S-transferase alpha 5 |
chr2_+_170366203 | 0.47 |
ENST00000284669.1 |
KLHL41 |
kelch-like family member 41 |
chr4_+_71063641 | 0.47 |
ENST00000514097.1 |
ODAM |
odontogenic, ameloblast asssociated |
chr5_+_82767284 | 0.46 |
ENST00000265077.3 |
VCAN |
versican |
chr11_-_128894053 | 0.46 |
ENST00000392657.3 |
ARHGAP32 |
Rho GTPase activating protein 32 |
chr1_-_48937838 | 0.46 |
ENST00000371847.3 |
SPATA6 |
spermatogenesis associated 6 |
chr15_+_69452959 | 0.45 |
ENST00000261858.2 |
GLCE |
glucuronic acid epimerase |
chr20_+_11871433 | 0.45 |
ENST00000399006.2 ENST00000405977.1 |
BTBD3 |
BTB (POZ) domain containing 3 |
chr6_-_112575687 | 0.45 |
ENST00000521398.1 ENST00000424408.2 ENST00000243219.3 |
LAMA4 |
laminin, alpha 4 |
chr6_-_112575912 | 0.45 |
ENST00000522006.1 ENST00000230538.7 ENST00000519932.1 |
LAMA4 |
laminin, alpha 4 |
chr3_+_158787041 | 0.44 |
ENST00000471575.1 ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
chr16_-_66584059 | 0.42 |
ENST00000417693.3 ENST00000544898.1 ENST00000569718.1 ENST00000527284.1 ENST00000299697.7 ENST00000451102.2 |
TK2 |
thymidine kinase 2, mitochondrial |
chr16_-_21436459 | 0.42 |
ENST00000448012.2 ENST00000504841.2 ENST00000419180.2 |
NPIPB3 |
nuclear pore complex interacting protein family, member B3 |
chr20_+_11871371 | 0.41 |
ENST00000254977.3 |
BTBD3 |
BTB (POZ) domain containing 3 |
chr16_-_15474904 | 0.41 |
ENST00000534094.1 |
NPIPA5 |
nuclear pore complex interacting protein family, member A5 |
chr2_-_111334678 | 0.40 |
ENST00000329516.3 ENST00000330331.5 ENST00000446930.1 |
RGPD6 |
RANBP2-like and GRIP domain containing 6 |
chr5_+_140762268 | 0.39 |
ENST00000518325.1 |
PCDHGA7 |
protocadherin gamma subfamily A, 7 |
chrX_-_131547625 | 0.37 |
ENST00000394311.2 |
MBNL3 |
muscleblind-like splicing regulator 3 |
chr21_-_43735628 | 0.37 |
ENST00000291525.10 ENST00000518498.1 |
TFF3 |
trefoil factor 3 (intestinal) |
chr1_-_92371839 | 0.37 |
ENST00000370399.2 |
TGFBR3 |
transforming growth factor, beta receptor III |
chr6_+_28092338 | 0.35 |
ENST00000340487.4 |
ZSCAN16 |
zinc finger and SCAN domain containing 16 |
chr6_-_52710893 | 0.35 |
ENST00000284562.2 |
GSTA5 |
glutathione S-transferase alpha 5 |
chr16_-_29415350 | 0.35 |
ENST00000524087.1 |
NPIPB11 |
nuclear pore complex interacting protein family, member B11 |
chr10_-_116444371 | 0.34 |
ENST00000533213.2 ENST00000369252.4 |
ABLIM1 |
actin binding LIM protein 1 |
chr14_+_57046500 | 0.34 |
ENST00000261556.6 |
TMEM260 |
transmembrane protein 260 |
chr14_-_90085458 | 0.34 |
ENST00000345097.4 ENST00000555855.1 ENST00000555353.1 |
FOXN3 |
forkhead box N3 |
chrX_-_131547596 | 0.33 |
ENST00000538204.1 ENST00000370849.3 |
MBNL3 |
muscleblind-like splicing regulator 3 |
chr15_-_99789736 | 0.33 |
ENST00000560235.1 ENST00000394132.2 ENST00000560860.1 ENST00000558078.1 ENST00000394136.1 ENST00000262074.4 ENST00000558613.1 ENST00000394130.1 ENST00000560772.1 |
TTC23 |
tetratricopeptide repeat domain 23 |
chrM_+_12331 | 0.32 |
ENST00000361567.2 |
MT-ND5 |
mitochondrially encoded NADH dehydrogenase 5 |
chr4_+_155484103 | 0.32 |
ENST00000302068.4 |
FGB |
fibrinogen beta chain |
chr16_+_48278178 | 0.31 |
ENST00000285737.4 ENST00000535754.1 |
LONP2 |
lon peptidase 2, peroxisomal |
chr19_+_42212501 | 0.31 |
ENST00000398599.4 |
CEACAM5 |
carcinoembryonic antigen-related cell adhesion molecule 5 |
chr19_+_13842559 | 0.31 |
ENST00000586600.1 |
CCDC130 |
coiled-coil domain containing 130 |
chrX_-_13835147 | 0.31 |
ENST00000493677.1 ENST00000355135.2 |
GPM6B |
glycoprotein M6B |
chr6_-_112575838 | 0.30 |
ENST00000455073.1 |
LAMA4 |
laminin, alpha 4 |
chr10_+_122610687 | 0.29 |
ENST00000263461.6 |
WDR11 |
WD repeat domain 11 |
chr11_+_22696314 | 0.29 |
ENST00000532398.1 ENST00000433790.1 |
GAS2 |
growth arrest-specific 2 |
chr11_+_22689648 | 0.29 |
ENST00000278187.3 |
GAS2 |
growth arrest-specific 2 |
chr6_-_47277634 | 0.29 |
ENST00000296861.2 |
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
chr16_-_29934558 | 0.29 |
ENST00000568995.1 ENST00000566413.1 |
KCTD13 |
potassium channel tetramerization domain containing 13 |
chr16_+_22524844 | 0.29 |
ENST00000538606.1 ENST00000424340.1 ENST00000517539.1 ENST00000528249.1 |
NPIPB5 |
nuclear pore complex interacting protein family, member B5 |
chr6_+_116601265 | 0.29 |
ENST00000452085.3 |
DSE |
dermatan sulfate epimerase |
chr16_-_21868739 | 0.28 |
ENST00000415645.2 |
NPIPB4 |
nuclear pore complex interacting protein family, member B4 |
chr20_+_30697298 | 0.28 |
ENST00000398022.2 |
TM9SF4 |
transmembrane 9 superfamily protein member 4 |
chr9_+_34652164 | 0.28 |
ENST00000441545.2 ENST00000553620.1 |
IL11RA |
interleukin 11 receptor, alpha |
chr6_+_158733692 | 0.28 |
ENST00000367094.2 ENST00000367097.3 |
TULP4 |
tubby like protein 4 |
chr2_+_109237717 | 0.28 |
ENST00000409441.1 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
chr16_+_24549014 | 0.27 |
ENST00000564314.1 ENST00000567686.1 |
RBBP6 |
retinoblastoma binding protein 6 |
chr10_+_90424196 | 0.27 |
ENST00000394375.3 ENST00000608620.1 ENST00000238983.4 ENST00000355843.2 |
LIPF |
lipase, gastric |
chr6_-_133035185 | 0.27 |
ENST00000367928.4 |
VNN1 |
vanin 1 |
chr2_-_179672142 | 0.27 |
ENST00000342992.6 ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN |
titin |
chr10_-_112678976 | 0.26 |
ENST00000448814.1 |
BBIP1 |
BBSome interacting protein 1 |
chr1_-_48937821 | 0.26 |
ENST00000396199.3 |
SPATA6 |
spermatogenesis associated 6 |
chr6_+_26365443 | 0.26 |
ENST00000527422.1 ENST00000356386.2 ENST00000396934.3 ENST00000377708.2 ENST00000396948.1 ENST00000508906.2 |
BTN3A2 |
butyrophilin, subfamily 3, member A2 |
chr16_+_28763108 | 0.26 |
ENST00000357796.3 ENST00000550983.1 |
NPIPB9 |
nuclear pore complex interacting protein family, member B9 |
chr5_+_156696362 | 0.25 |
ENST00000377576.3 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
chr3_+_138340067 | 0.25 |
ENST00000479848.1 |
FAIM |
Fas apoptotic inhibitory molecule |
chr11_-_18548426 | 0.25 |
ENST00000357193.3 ENST00000536719.1 |
TSG101 |
tumor susceptibility 101 |
chrX_-_114252193 | 0.25 |
ENST00000243213.1 |
IL13RA2 |
interleukin 13 receptor, alpha 2 |
chr16_-_21868978 | 0.25 |
ENST00000357370.5 ENST00000451409.1 ENST00000341400.7 ENST00000518761.4 |
NPIPB4 |
nuclear pore complex interacting protein family, member B4 |
chr7_-_137028534 | 0.25 |
ENST00000348225.2 |
PTN |
pleiotrophin |
chr19_-_43382142 | 0.24 |
ENST00000597058.1 |
PSG1 |
pregnancy specific beta-1-glycoprotein 1 |
chr1_-_21377383 | 0.24 |
ENST00000374935.3 |
EIF4G3 |
eukaryotic translation initiation factor 4 gamma, 3 |
chr8_+_132952112 | 0.24 |
ENST00000520362.1 ENST00000519656.1 |
EFR3A |
EFR3 homolog A (S. cerevisiae) |
chr3_-_11685345 | 0.24 |
ENST00000430365.2 |
VGLL4 |
vestigial like 4 (Drosophila) |
chr11_-_59950519 | 0.24 |
ENST00000528851.1 |
MS4A6A |
membrane-spanning 4-domains, subfamily A, member 6A |
chr6_+_153552455 | 0.24 |
ENST00000392385.2 |
AL590867.1 |
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
chr7_+_138943265 | 0.24 |
ENST00000483726.1 |
UBN2 |
ubinuclein 2 |
chr11_-_35287243 | 0.23 |
ENST00000464522.2 |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr5_+_95066823 | 0.23 |
ENST00000506817.1 ENST00000379982.3 |
RHOBTB3 |
Rho-related BTB domain containing 3 |
chr7_-_137028498 | 0.23 |
ENST00000393083.2 |
PTN |
pleiotrophin |
chr16_-_66583701 | 0.22 |
ENST00000527800.1 ENST00000525974.1 ENST00000563369.2 |
TK2 |
thymidine kinase 2, mitochondrial |
chr2_+_239335449 | 0.22 |
ENST00000264607.4 |
ASB1 |
ankyrin repeat and SOCS box containing 1 |
chr14_-_35591433 | 0.22 |
ENST00000261475.5 ENST00000555644.1 |
PPP2R3C |
protein phosphatase 2, regulatory subunit B'', gamma |
chr12_-_12503156 | 0.21 |
ENST00000543314.1 ENST00000396349.3 |
MANSC1 |
MANSC domain containing 1 |
chr17_+_67498538 | 0.21 |
ENST00000589647.1 |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
chr14_-_68283291 | 0.20 |
ENST00000555452.1 ENST00000347230.4 |
ZFYVE26 |
zinc finger, FYVE domain containing 26 |
chr12_-_8803128 | 0.20 |
ENST00000543467.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr20_+_1099233 | 0.20 |
ENST00000246015.4 ENST00000335877.6 ENST00000438768.2 |
PSMF1 |
proteasome (prosome, macropain) inhibitor subunit 1 (PI31) |
chr6_-_112575758 | 0.20 |
ENST00000431543.2 ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4 |
laminin, alpha 4 |
chr7_-_44122063 | 0.20 |
ENST00000335195.6 ENST00000395831.3 ENST00000414235.1 ENST00000452049.1 ENST00000242248.5 |
POLM |
polymerase (DNA directed), mu |
chr18_-_10701979 | 0.19 |
ENST00000538948.1 ENST00000285141.4 |
PIEZO2 |
piezo-type mechanosensitive ion channel component 2 |
chr7_+_142498725 | 0.19 |
ENST00000466254.1 |
TRBC2 |
T cell receptor beta constant 2 |
chr10_+_91152303 | 0.19 |
ENST00000371804.3 |
IFIT1 |
interferon-induced protein with tetratricopeptide repeats 1 |
chr3_-_185538849 | 0.19 |
ENST00000421047.2 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr10_-_112678692 | 0.19 |
ENST00000605742.1 |
BBIP1 |
BBSome interacting protein 1 |
chr2_+_109204909 | 0.19 |
ENST00000393310.1 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
chr19_-_51920952 | 0.19 |
ENST00000356298.5 ENST00000339313.5 ENST00000529627.1 ENST00000439889.2 ENST00000353836.5 ENST00000432469.2 |
SIGLEC10 |
sialic acid binding Ig-like lectin 10 |
chr14_+_57046530 | 0.19 |
ENST00000536419.1 ENST00000538838.1 |
TMEM260 |
transmembrane protein 260 |
chr2_+_109204743 | 0.19 |
ENST00000332345.6 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
chr2_+_102953608 | 0.19 |
ENST00000311734.2 ENST00000409584.1 |
IL1RL1 |
interleukin 1 receptor-like 1 |
chr16_+_28648975 | 0.19 |
ENST00000529716.1 |
NPIPB8 |
nuclear pore complex interacting protein family, member B8 |
chr2_+_210517895 | 0.19 |
ENST00000447185.1 |
MAP2 |
microtubule-associated protein 2 |
chr10_-_79789291 | 0.18 |
ENST00000372371.3 |
POLR3A |
polymerase (RNA) III (DNA directed) polypeptide A, 155kDa |
chr10_+_124320156 | 0.18 |
ENST00000338354.3 ENST00000344338.3 ENST00000330163.4 ENST00000368909.3 ENST00000368955.3 ENST00000368956.2 |
DMBT1 |
deleted in malignant brain tumors 1 |
chr2_-_58468437 | 0.18 |
ENST00000403676.1 ENST00000427708.2 ENST00000403295.3 ENST00000446381.1 ENST00000417361.1 ENST00000233741.4 ENST00000402135.3 ENST00000540646.1 ENST00000449070.1 |
FANCL |
Fanconi anemia, complementation group L |
chr3_-_160823158 | 0.18 |
ENST00000392779.2 ENST00000392780.1 ENST00000494173.1 |
B3GALNT1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
chr5_-_139726181 | 0.18 |
ENST00000507104.1 ENST00000230990.6 |
HBEGF |
heparin-binding EGF-like growth factor |
chr8_-_93115445 | 0.18 |
ENST00000523629.1 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chrX_+_1710484 | 0.17 |
ENST00000313871.3 ENST00000381261.3 |
AKAP17A |
A kinase (PRKA) anchor protein 17A |
chr3_+_138340049 | 0.17 |
ENST00000464668.1 |
FAIM |
Fas apoptotic inhibitory molecule |
chr18_-_51750948 | 0.17 |
ENST00000583046.1 ENST00000398398.2 |
MBD2 |
methyl-CpG binding domain protein 2 |
chr16_+_67880574 | 0.17 |
ENST00000219169.4 |
NUTF2 |
nuclear transport factor 2 |
chr5_-_74162605 | 0.17 |
ENST00000389156.4 ENST00000510496.1 ENST00000380515.3 |
FAM169A |
family with sequence similarity 169, member A |
chr16_-_28374829 | 0.17 |
ENST00000532254.1 |
NPIPB6 |
nuclear pore complex interacting protein family, member B6 |
chr1_+_12976450 | 0.17 |
ENST00000361079.2 |
PRAMEF7 |
PRAME family member 7 |
chr10_-_112678904 | 0.16 |
ENST00000423273.1 ENST00000436562.1 ENST00000447005.1 ENST00000454061.1 |
BBIP1 |
BBSome interacting protein 1 |
chrX_+_55744228 | 0.16 |
ENST00000262850.7 |
RRAGB |
Ras-related GTP binding B |
chr19_-_53758094 | 0.16 |
ENST00000601828.1 ENST00000598513.1 ENST00000599012.1 ENST00000333952.4 ENST00000598806.1 |
ZNF677 |
zinc finger protein 677 |
chr1_+_221051699 | 0.16 |
ENST00000366903.6 |
HLX |
H2.0-like homeobox |
chr1_-_67142710 | 0.16 |
ENST00000502413.2 |
AL139147.1 |
Uncharacterized protein |
chr11_+_7618413 | 0.15 |
ENST00000528883.1 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr3_-_160823040 | 0.15 |
ENST00000484127.1 ENST00000492353.1 ENST00000473142.1 ENST00000468268.1 ENST00000460353.1 ENST00000320474.4 ENST00000392781.2 |
B3GALNT1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
chr6_-_52668605 | 0.15 |
ENST00000334575.5 |
GSTA1 |
glutathione S-transferase alpha 1 |
chr2_+_211342432 | 0.15 |
ENST00000430249.2 |
CPS1 |
carbamoyl-phosphate synthase 1, mitochondrial |
chr5_-_10761206 | 0.15 |
ENST00000432074.2 ENST00000230895.6 |
DAP |
death-associated protein |
chr12_+_14572070 | 0.15 |
ENST00000545769.1 ENST00000428217.2 ENST00000396279.2 ENST00000542514.1 ENST00000536279.1 |
ATF7IP |
activating transcription factor 7 interacting protein |
chr1_+_196788887 | 0.15 |
ENST00000320493.5 ENST00000367424.4 ENST00000367421.3 |
CFHR1 CFHR2 |
complement factor H-related 1 complement factor H-related 2 |
chr19_+_16940198 | 0.15 |
ENST00000248054.5 ENST00000596802.1 ENST00000379803.1 |
SIN3B |
SIN3 transcription regulator family member B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 0.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.1 | 1.8 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.7 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 2.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.1 | GO:0000806 | Y chromosome(GO:0000806) |
0.0 | 0.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 1.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 1.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 2.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 1.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 1.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.1 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.7 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 2.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 2.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.6 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.3 | 1.1 | GO:0047718 | enone reductase activity(GO:0035671) androsterone dehydrogenase activity(GO:0047023) indanol dehydrogenase activity(GO:0047718) |
0.2 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.6 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.2 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.8 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 1.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 1.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
0.1 | 1.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 0.6 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 0.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 3.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 2.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 2.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.6 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 1.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 1.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 1.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 2.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 3.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 3.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 2.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 2.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 1.9 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 1.3 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.9 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.3 | 0.8 | GO:0060503 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.2 | 1.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 1.5 | GO:0042426 | choline catabolic process(GO:0042426) |
0.2 | 0.6 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 1.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.5 | GO:1900158 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.2 | 0.6 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.5 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.2 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.9 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 1.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.6 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 1.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 2.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 1.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0035995 | skeletal muscle myosin thick filament assembly(GO:0030241) detection of muscle stretch(GO:0035995) |
0.1 | 2.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 2.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.2 | GO:2000395 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.8 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.2 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.6 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.5 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.0 | 0.1 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.0 | 0.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 1.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.9 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 1.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
0.0 | 0.5 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.0 | 5.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.0 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0034343 | microglial cell activation involved in immune response(GO:0002282) type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 1.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) response to oleic acid(GO:0034201) |
0.0 | 1.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.2 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.5 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.0 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.0 | 2.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.1 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.3 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0070543 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.0 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 1.2 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.4 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) NMDA glutamate receptor clustering(GO:0097114) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
0.0 | 0.0 | GO:1903056 | regulation of melanosome organization(GO:1903056) |